Cargando…

Clinical management of autoimmune hepatitis

Autoimmune hepatitis is a rare and chronic liver disease that is characterised by increased serum transaminases and immunoglobulin G, inflammatory liver histology and presence of circulating autoantibodies. An autoimmune hepatitis diagnosis justifies life-long treatment in most patients in order to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pape, Simon, Schramm, Christoph, Gevers, Tom JG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826525/ https://www.ncbi.nlm.nih.gov/pubmed/31700628 http://dx.doi.org/10.1177/2050640619872408

Ejemplares similares

Health-related quality of life in autoimmune hepatitis
por: Snijders, Romée JALM, et al.
Publicado: (2021)

Confidence in treatment is contributing to quality of life in autoimmune liver diseases. The results of ERN RARE‐LIVER online survey
por: Wunsch, Ewa, et al.
Publicado: (2022)

High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation
por: Pape, Simon, et al.
Publicado: (2020)

Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
por: Than, Nwe Ni, et al.
Publicado: (2019)

Recent updates on the management of autoimmune hepatitis
por: Komori, Atsumasa
Publicado: (2021)

Ultrasound findings in autoimmune hepatitis
por: Dong, Yi, et al.
Publicado: (2018)

Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis
por: Harrington, Claire, et al.
Publicado: (2022)

Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease
por: Kapila, Nikhil, et al.
Publicado: (2013)

Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial
por: Wijnands, Titus FM, et al.
Publicado: (2015)

Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions
por: Czaja, Albert J.
Publicado: (2016)

Introducing Molecular Chaperones into the Causality and Prospective Management of Autoimmune Hepatitis
por: Czaja, Albert J.
Publicado: (2023)

The intestinal and biliary microbiome in autoimmune liver disease—current evidence and concepts
por: Liwinski, Timur, et al.
Publicado: (2022)

Acute hepatitis after COVID-19 vaccine: case series by the International autoimmune hepatitis group (IAIHG) and the european reference network on hepatological diseases (ERN RARE-LIVER)
por: Codoni, Greta, et al.
Publicado: (2022)

Pathology of autoimmune hepatitis
por: Covelli, Claudia, et al.
Publicado: (2021)

Autoimmune Hepatitis and Fibrosis
por: Pellicano, Rinaldo, et al.
Publicado: (2023)

B cells in autoimmune hepatitis: bystanders or central players?
por: Schultheiß, Christoph, et al.
Publicado: (2022)

KASL clinical practice guidelines for management of autoimmune hepatitis 2022
Publicado: (2023)

Autoimmune encephalitis: clinical spectrum and management
por: Uy, Christopher E, et al.
Publicado: (2021)

Update on Autoimmune Hepatitis
por: Liberal, Rodrigo, et al.
Publicado: (2015)

Seronegative Autoimmune Hepatitis
por: Bhumi, Sriya A., et al.
Publicado: (2023)

Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance
por: Sebode, Marcial, et al.
Publicado: (2018)

Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview
por: Fallatah, Hind I., et al.
Publicado: (2012)

Autoimmune hepatitis and COVID-19: No increased risk for AIH after vaccination but reduced care
por: Rüther, Darius Ferenc, et al.
Publicado: (2022)

Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis
por: Laschtowitz, Alena, et al.
Publicado: (2021)

Ethanol sclerotherapy or polidocanol sclerotherapy for symptomatic hepatic cysts
por: Wijnands, Titus FM, et al.
Publicado: (2018)

Epidemiology and treatment of autoimmune hepatitis
por: Francque, Sven, et al.
Publicado: (2012)

Autoimmune Hepatitis: 2019 Update
por: Tanaka, Atsushi
Publicado: (2020)

Juvenile Autoimmune Hepatitis: Recent Advances in Diagnosis, Management and Long-Term Outcome
por: Nastasio, Silvia, et al.
Publicado: (2023)

Xenobiotic Exposure and Autoimmune Hepatitis
por: Gilbert, Kathleen M.
Publicado: (2010)

Hepatitis C virus and autoimmunity
por: Böckle, Barbara C., et al.
Publicado: (2010)

Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience
por: Pape, Simon, et al.
Publicado: (2020)

The immunopathogenetic role of autoantibodies in canine autoimmune hepatitis: lessons to learn from human autoimmune hepatitis
por: Liaskos, Christos, et al.
Publicado: (2012)

Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots: A Review
por: Madhu, Deepak, et al.
Publicado: (2021)

Tolerance and autoimmunity in the liver
por: Schramm, Christoph, et al.
Publicado: (2022)

Autoimmune Hepatitis: Treatment Options and Management Review
por: Gadour, Eyad
Publicado: (2021)

The Role of Vitamin D in Autoimmune Hepatitis
por: Luong, Khanh vinh quoc, et al.
Publicado: (2013)

Etiopathogenesis and Diagnostic Strategies in Autoimmune Hepatitis
por: Domerecka, Weronika, et al.
Publicado: (2021)

Stem cell therapies for autoimmune hepatitis
por: Lotfy, Ahmed, et al.
Publicado: (2021)

SARS-CoV-2 infection in patients with autoimmune hepatitis
por: Marjot, Thomas, et al.
Publicado: (2021)

Autoimmune Hepatitis in the Asia-Pacific Area
por: Wang, Qi-Xia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uiej0pc6uuh54uism5a4siqknq